Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $140.24 Analyst target: $178.57 Upside: 27.33%
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
See the full interactive analysis & chart →Informational only — not investment advice.